Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02909114 | Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer | unknown | Phase 2 | 50 | Jing Jin, M.D.UNKNOWN | 1 | Sep 21, 2016 | clinicaltrials |
| NCT02905968 | Transanual Tube Placement in Low Anterior Resection (LAR) for Rectal Cancer | unknown | Phase 2 / Phase 3 | 520 | Fudan UniversityOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02893540 |
| Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC |
| unknown |
| Phase 2 / Phase 3 |
| 250 |
| Ruijin HospitalOTHER |
| 1 |
| Sep 16, 2016 |
| clinicaltrials |
| NCT02476045 | Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)(Valentino) | unknown | Phase 2 | 224 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 14, 2016 | clinicaltrials |
| NCT02886897 | A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors | unknown | Phase 1 / Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2016 | clinicaltrials |
| NCT02882269 | Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer | unknown | Phase 2 / Phase 3 | 400 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Aug 30, 2016 | clinicaltrials |
| NCT02830633 | Trial to Evaluate Laparoscopy-assisted Nerve-preserved Total Mesorectal Excision (LNTME) Versus Open TME for Rectal Cancer | unknown | Phase 2 | 80 | Anhui Medical UniversityOTHER | 0 | Jul 13, 2016 | clinicaltrials |
| NCT00754078 | A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy | unknown | Phase 2 | 58 | AHS Cancer Control AlbertaOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02603302 | Radiation Dose Escalation in Locally Advanced Rectal Cancer(RaDE) | unknown | Phase 2 | 48 | University of BrasiliaOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT01708824 | Diet and Physical Activity Intervention in CRC Survivors | unknown | Phase 2 | 224 | The University of Hong KongOTHER | 1 | May 12, 2016 | clinicaltrials |
| NCT02591667 | Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer(CARCINOSIS) | unknown | Phase 2 | 30 | Medical University of ViennaOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT01626963 | Single-port Versus Conventional Laparoscopic Colorectal Surgery | unknown | Phase 1 / Phase 2 | 50 | North Tees and Hartlepool NHS Foundation TrustOTHER | 1 | Mar 24, 2016 | clinicaltrials |
| NCT02688023 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer | unknown | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02466906 | RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer | unknown | Phase 2 | 60 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT01675999 | Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer(ECKINOXE) | unknown | Phase 2 | 186 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT01257360 | Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III)(NEO-RIT) | unknown | Phase 2 | 59 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Jan 13, 2016 | clinicaltrials |
| NCT02068131 | Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02202928 | Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | Dec 28, 2015 | clinicaltrials |
| NCT02291744 | A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients | unknown | Phase 2 | 130 | Fudan UniversityOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT02051868 | International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel(InterAACT) | unknown | Phase 2 | 80 | Royal Marsden NHS Foundation TrustOTHER | 3 | Nov 4, 2015 | clinicaltrials |
| NCT01882946 | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Northwest BiotherapeuticsINDUSTRY | 1 | Oct 7, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02515734 | A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab(DEEPER) | unknown | Phase 2 | 360 | Japan Clinical Cancer Research OrganizationOTHER | 0 | Aug 5, 2015 | clinicaltrials |
| NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | unknown | Phase 2 / Phase 3 | 360 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 3, 2015 | clinicaltrials |
| NCT02510378 | Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases | unknown | Phase 2 | 47 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT02490709 | Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy | unknown | Phase 2 | 86 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 7, 2015 | clinicaltrials |
| NCT02488707 | Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).(MISS-TRICR) | unknown | Phase 2 | 250 | Mansoura UniversityOTHER | 1 | Jul 2, 2015 | clinicaltrials |
| NCT01818973 | Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer | unknown | Phase 2 | 45 | Sun Yat-sen UniversityOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer(FOWARC) | unknown | Phase 2 / Phase 3 | 495 | Sun Yat-sen UniversityOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT01639326 | Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1(FOLFIRI-AD) | unknown | Phase 2 | 96 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | unknown | Phase 2 / Phase 3 | 100 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Apr 14, 2015 | clinicaltrials |
| NCT02415829 | Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients | unknown | Phase 2 | 55 | Fudan UniversityOTHER | 1 | Apr 14, 2015 | clinicaltrials |
| NCT02075086 | Angiogenic Switch in Patients With Colorectal Cancer(ANGIOSWITCH) | unknown | Phase 2 | 100 | Grupo Hospital de MadridOTHER | 1 | Mar 17, 2015 | clinicaltrials |
| NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Mar 3, 2015 | clinicaltrials |
| NCT02195141 | Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer | unknown | Phase 2 | 104 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT02288078 | Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402) | unknown | Phase 2 | 74 | Clinical Research Support Center KyushOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | unknown | Phase 2 | 110 | Clinical Research Support Center KyushOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT02268006 | IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment(BISER) | unknown | Phase 2 | 50 | Institute of Oncology LjubljanaOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT02216487 | Trial of FOLF(HA)Iri With Cetuximab in mCRC(Chime) | unknown | Phase 2 | 45 | Western General Hospital, AustraliaOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | unknown | Phase 2 | 118 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Aug 8, 2014 | clinicaltrials |
| NCT02177084 | Percutaneous Tibial Nerve Stimulation in the Treatment of Anterior Resection Syndrome After Rectal Cancer Surgery | unknown | Phase 2 | 12 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jun 27, 2014 | clinicaltrials |
| NCT02128425 | FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer | unknown | Phase 2 | 162 | Sun Yat-sen UniversityOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT02117557 | Safety Study of Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer | unknown | Phase 2 | 198 | Guoxin LiOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | unknown | Phase 2 / Phase 3 | 300 | Taichung Veterans General HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00795301 | A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab | unknown | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00967655 | Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer | unknown | Phase 2 | 54 | Loma Linda Oncology Medical Group, Inc.OTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01067053 | Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.(BECOX) | unknown | Phase 2 | 69 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 2 | Jan 6, 2014 | clinicaltrials |
| NCT02022852 | Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Sep 21, 2016source: clinicaltrials